Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Chongqing Daxin Pharmaceutical Co., Ltd.
483
•Chongqing Daxin Pharmaceutical Co., Ltd.•June 28, 2024

Chongqing Daxin Pharmaceutical Co., Ltd. – FDA 483, Jun 28, 2024

Record Details

An FDA inspection of Chongqing Daxin Pharmaceutical Co., Ltd. in Chongqing, China, was conducted from June 24-28, 2024. The U.S. Food and Drug Administration issued a Form FDA 483, highlighting two critical observations indicating deviations from established good manufacturing practices for Active Pharmaceutical Ingredients (APIs).

Firstly, inspectors noted that written procedures for cleaning equipment used in API manufacturing were not followed. Specifically, equipment labeled "Cleaned," including tanks and reactors, was found to have visible material residue and cotton-like threads. This lapse in sanitation practices raises concerns about potential cross-contamination and product quality.

Secondly, the facility lacked adequate environmental controls, as there were no instruments to monitor the temperature in rooms designated for API packaging processes. Monitoring these conditions is crucial, as specific temperature requirements are essential for maintaining the stability and integrity of finished APIs. The absence of such monitoring poses a risk to product quality and efficacy.

Chongqing Daxin Pharmaceutical Co., Ltd. is now expected to provide a comprehensive response detailing corrective and preventive actions to address these observations and ensure compliance with regulatory standards for pharmaceutical manufacturing.

Company
Chongqing Daxin Pharmaceutical Co., Ltd.
Inspection date
June 28, 2024
Product type
drugs
Office
Baltimore District Office
People
  • Maria T. Bradfish (company_representative)
  • Gavin T. Cua (issuing_officer)
View Company Profile

ID · 307e313b-3e1a-4cce-a698-75b4070f514a

Other documents for Chongqing Daxin Pharmaceutical Co., Ltd.
  • 483 - 2018-05-11May 11, 2018
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chongqing Daxin Pharmaceutical Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.